FindTrial
Sign In

Study on the effect and mechanism of estrogen deficiency on female pelvic organ prolapse based on intestinal flora

Study on the effect and mechanism of estrogen deficiency on female pelvic organ prolapse based on intestinal flora

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051495
Enrollment
Unknown
Registered
2021-09-24
Start date
2021-09-24
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

Case group:none
Control Group:No

Sponsors

Chengdu Women and Children Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Case group: Diagnosis of pelvic organ prolapse according to the Quantitative Classification of Pelvic Organ Prolapse (POP-Q); Control group: benign gynecological disease without pelvic organ prolapse.

Exclusion criteria

Exclusion criteria: 1. Past cancer history; 2. History of inflammatory bowel disease or diverticulitis, gastric banding or bypass surgery, other gastric or bowel surgery (such as appendicitis) within the past 6 months; 3. Use of estrogen in the past 3 months; 4. Use of antibiotics within the past 1 month; 5. Known human immunodeficiency virus (HIV) infection; 6. Other investigators deem it inappropriate for this clinical trial.

Design outcomes

Primary

MeasureTime frame
Metabonomics;Transcriptome;—

Countries

Chian

Contacts

Public ContactYu Xia

Chengdu Women and Children Central Hospital

410445562@qq.com+86 18190811231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026